Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab
Titel:
Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab
Auteur:
Guhl, G. Díaz-Ley, B. Fernández-Herrera, J.
Verschenen in:
Actas dermo-sifiliograficas
Paginering:
Jaargang 99 (2008) nr. 1 pagina's 29 p.
Jaar:
2008
Inhoud:
Uitgever:
Academia Española de Dermatología y Venereología and Elsevier España, S.L.